SYK Activation Enhances Dendritic Cell Functions in Spontaneous Rheumatoid Arthritis
Open Access
- 30 December 2025
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 49 (1)
Abstract
The pathogenesis of rheumatoid arthritis (RA) involves an aberrant number and/or activation of dendritic cells (DCs) within the synovial microenvironment. Targeting synovial DCs represents an attractive approach for the treatment of RA. Spleen tyrosine kinase (SYK), a pivotal molecule in immune cell receptor signaling pathways, is known to play a critical role in RA progression. However, the impact of SYK on DC biology under RA-specific pathological conditions remains incompletely understood. In this study, we employed a spontaneous RA mouse model carrying a gain-of-function SYK variant (SYKS544Y) to investigate the effects of SYK activation on DCs. Our findings demonstrate that SYK activation promotes the expansion of the DCs population (CD11C+MHCII+), particularly the CD11C+MHCII+CD11B+CD8a− subtype, in blood, spleen, and ankle. Furthermore, SYK activation enhances DC maturation and endocytosis by upregulating CD40 and CD86. Additionally, bone-marrow-derived DCs from SYKS544Y mice exhibit increased T-cell proliferative activity. Collectively, these results suggest that gain-of-function SYK may contribute to RA pathogenesis by promoting DC expansion and maturation, thereby modulating immune responses in the synovial environment.Keywords
Funding Information
- National Natural Science Foundation of China (32200732)
- National Natural Science Foundation of China (32200732)
- National Natural Science Foundation of China (32200732)
- National Natural Science Foundation of China (32200732)
- National Natural Science Foundation of China (32200732)
- National Natural Science Foundation of China (32200732)
- National Natural Science Foundation of China (32200732)
- Shanghai Municipal Commission for Science and Technology (22YF1437700)
- Shanghai Municipal Commission for Science and Technology (22YF1437700)
- Shanghai Municipal Commission for Science and Technology (22YF1437700)
- Shanghai Municipal Commission for Science and Technology (22YF1437700)
- Shanghai Municipal Commission for Science and Technology (22YF1437700)
- Shanghai Municipal Commission for Science and Technology (22YF1437700)
- Shanghai Municipal Commission for Science and Technology (22YF1437700)
- the Key Medical Disciplines of Shanghai Municipal Health Commission (2024ZDXK0045)
- the Key Medical Disciplines of Shanghai Municipal Health Commission (2024ZDXK0045)
- the Key Medical Disciplines of Shanghai Municipal Health Commission (2024ZDXK0045)
- the Key Medical Disciplines of Shanghai Municipal Health Commission (2024ZDXK0045)
- the Key Medical Disciplines of Shanghai Municipal Health Commission (2024ZDXK0045)
- the Key Medical Disciplines of Shanghai Municipal Health Commission (2024ZDXK0045)
- the Key Medical Disciplines of Shanghai Municipal Health Commission (2024ZDXK0045)
- the Key Medical Disciplines of Shanghai Municipal Health Commission (2024ZDXK0045)
- National Key Research and Development Program of China (2023YFC3403400)
- National Key Research and Development Program of China (2023YFC3403400)
- National Key Research and Development Program of China (2023YFC3403400)
- National Key Research and Development Program of China (2023YFC3403400)
- National Key Research and Development Program of China (2023YFC3403400)
- National Key Research and Development Program of China (2023YFC3403400)
- National Key Research and Development Program of China (2023YFC3403400)
- National Key Research and Development Program of China (2023YFC3403400)
- Innovation Program of Shanghai Municipal Education Commission (2019-01-07-00-05-E00054)
- Innovation Program of Shanghai Municipal Education Commission (2019-01-07-00-05-E00054)
- Innovation Program of Shanghai Municipal Education Commission (2019-01-07-00-05-E00054)
- Innovation Program of Shanghai Municipal Education Commission (2019-01-07-00-05-E00054)
- Innovation Program of Shanghai Municipal Education Commission (2019-01-07-00-05-E00054)
- Innovation Program of Shanghai Municipal Education Commission (2019-01-07-00-05-E00054)
- Innovation Program of Shanghai Municipal Education Commission (2019-01-07-00-05-E00054)
- Innovation Program of Shanghai Municipal Education Commission (2019-01-07-00-05-E00054)
- Innovation Program of Shanghai Municipal Education Commission (2019-01-07-00-05-E00054)
This publication has 38 references indexed in Scilit:
- Imbalance of Th17, Treg, and helper innate lymphoid cell in the peripheral blood of patients with rheumatoid arthritisClinical Rheumatology, 2022
- Innate immunity drives pathogenesis of rheumatoid arthritisBiomedical Journal, 2021
- Activation of Syk in Peripheral Blood B Cells in Patients With Rheumatoid Arthritis: A Potential Target for Abatacept TherapyArthritis & Rheumatology, 2014
- An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: A three‐month randomized, placebo‐controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agentsArthritis & Rheumatism, 2010
- Genetic deficiency of Syk protects mice from autoantibody‐induced arthritisArthritis & Rheumatism, 2010
- Dendritic Cells and their Potential Implication in Pathology and Treatment of Rheumatoid Arthritis2008
- Stimulation of nicotinic acetylcholine receptors attenuates collagen‐induced arthritis in miceArthritis & Rheumatism, 2008
- Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitorClinical Immunology, 2007
- RANK and RANKL expression as markers of dendritic cell–t cell interactions in paired samples of rheumatoid synovium and lymph nodesArthritis & Rheumatism, 2005
- Differentiated dendritic cells expressing nuclear RelB are predominantly located in rheumatoid synovial tissue perivascular mononuclear cell aggregatesArthritis & Rheumatism, 2000